Effects of a low-carbohydrate diet on weight loss and cardiometabolic profile in Chinese women: a randomised controlled feeding trial - PubMed (original) (raw)

Randomized Controlled Trial

. 2013 Oct;110(8):1444-53.

doi: 10.1017/S0007114513000640. Epub 2013 Mar 25.

Affiliations

• PMID: 23522432
• DOI: 10.1017/S0007114513000640

Randomized Controlled Trial

Effects of a low-carbohydrate diet on weight loss and cardiometabolic profile in Chinese women: a randomised controlled feeding trial

Xin Liu et al. Br J Nutr. 2013 Oct.

Abstract

Little is known about the potential adherence to and the effectiveness of a low-carbohydrate (LC) diet on weight loss and cardiometabolic risk factors in Chinese adults with a habitually high carbohydrate intake. In the present controlled feeding trial, fifty overweight or obese women (age 47·9 (sem 0·9) years; BMI 26·7 (sem 0·3) kg/m²) were randomly assigned to a LC non-energy-restricted diet (initial carbohydrate intake 20 g/d, with a 10 g increase weekly) or an energy-restricted (ER) diet (carbohydrate intake 156-205 g/d, ER to 5021 or 6276 kJ/d, 35% average energy reduction) for 12 weeks. Over the intervention period, the two diets had comparable compliance (96%) and self-reported acceptability. At week 12, carbohydrate intake in the LC and ER groups contributed to 36·1 and 51·1% of total energy, respectively (P < 0·001). Although both diets showed similarly decreased mean body weight (LC - 5·27 (95% CI - 6·08, - 4·46) kg; ER - 5·09 (95% CI - 5·50, - 4·67) kg, P = 0·67) and percentage of fat mass measured by dual-energy X-ray absorptiometry (LC - 1·19 (95% CI - 1·88, - 0·50)%; ER - 1·56 (95% CI - 2·20, - 0·92)%, P = 0·42), participants in the LC group had greater reductions in the ratio of total cholesterol:HDL-cholesterol (P= 0·03) and also in the ratio of TAG:HDL-cholesterol (P = 0·01) than those in the ER group. The present 12-week diet trial suggested that both a LC non-energy-restricted diet and an ER diet were acceptable to Chinese women and both diets were equally effective in reducing weight and fat mass. Moreover, the LC diet showed beneficial effects on blood lipid profiles.

PubMed Disclaimer

Similar articles

• Effects of a high-protein, low-carbohydrate v. high-protein, moderate-carbohydrate weight-loss diet on antioxidant status, endothelial markers and plasma indices of the cardiometabolic profile.
  Johnstone AM, Lobley GE, Horgan GW, Bremner DM, Fyfe CL, Morrice PC, Duthie GG. Johnstone AM, et al. Br J Nutr. 2011 Jul;106(2):282-91. doi: 10.1017/S0007114511000092. Br J Nutr. 2011. PMID: 21521539 Clinical Trial.
• Intake of milk with added micronutrients increases the effectiveness of an energy-restricted diet to reduce body weight: a randomized controlled clinical trial in Mexican women.
  Rosado JL, Garcia OP, Ronquillo D, Hervert-Hernández D, Caamaño Mdel C, Martínez G, Gutiérrez J, García S. Rosado JL, et al. J Am Diet Assoc. 2011 Oct;111(10):1507-16. doi: 10.1016/j.jada.2011.07.011. J Am Diet Assoc. 2011. PMID: 21963017 Clinical Trial.
• Comparison of 4 diets of varying glycemic load on weight loss and cardiovascular risk reduction in overweight and obese young adults: a randomized controlled trial.
  McMillan-Price J, Petocz P, Atkinson F, O'neill K, Samman S, Steinbeck K, Caterson I, Brand-Miller J. McMillan-Price J, et al. Arch Intern Med. 2006 Jul 24;166(14):1466-75. doi: 10.1001/archinte.166.14.1466. Arch Intern Med. 2006. PMID: 16864756 Clinical Trial.
• Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials.
  Nordmann AJ, Nordmann A, Briel M, Keller U, Yancy WS Jr, Brehm BJ, Bucher HC. Nordmann AJ, et al. Arch Intern Med. 2006 Feb 13;166(3):285-93. doi: 10.1001/archinte.166.3.285. Arch Intern Med. 2006. PMID: 16476868 Review.
• Effects of macronutrient intake in obesity: a meta-analysis of low-carbohydrate and low-fat diets on markers of the metabolic syndrome.
  Willems AEM, Sura-de Jong M, van Beek AP, Nederhof E, van Dijk G. Willems AEM, et al. Nutr Rev. 2021 Mar 9;79(4):429-444. doi: 10.1093/nutrit/nuaa044. Nutr Rev. 2021. PMID: 32885229 Free PMC article. Review.

Cited by

• High Protein Diets and Glomerular Hyperfiltration in Athletes and Bodybuilders: Is Chronic Kidney Disease the Real Finish Line?
  de Lorenzo A, Bomback AS, Mihic N. de Lorenzo A, et al. Sports Med. 2024 Oct;54(10):2481-2495. doi: 10.1007/s40279-024-02086-1. Epub 2024 Aug 28. Sports Med. 2024. PMID: 39196487 Review.
• Ketogenic diet-induced bile acids protect against obesity through reduced calorie absorption.
  Li X, Yang J, Zhou X, Dai C, Kong M, Xie L, Liu C, Liu Y, Li D, Ma X, Dai Y, Sun Y, Jian Z, Guo X, Lin X, Li Y, Sun L, Liu X, Jin L, Tang H, Zheng Y, Hong S. Li X, et al. Nat Metab. 2024 Jul;6(7):1397-1414. doi: 10.1038/s42255-024-01072-1. Epub 2024 Jun 27. Nat Metab. 2024. PMID: 38937659
• The impact of ketogenic diet on some metabolic and non-metabolic diseases: Evidence from human and animal model experiments.
  Galali Y, Zebari SMS, Aj Jabbar A, Hashm Balaky H, Sadee BA, Hassanzadeh H. Galali Y, et al. Food Sci Nutr. 2024 Jan 8;12(3):1444-1464. doi: 10.1002/fsn3.3873. eCollection 2024 Mar. Food Sci Nutr. 2024. PMID: 38455178 Free PMC article. Review.
• A Novel Multiphase Modified Ketogenic Diet: An Effective and Safe Tool for Weight Loss in Chinese Obese Patients.
  Wu W, Zhou Q, Yuan P, Qiao D, Deng S, Cheng H, Ren Y. Wu W, et al. Diabetes Metab Syndr Obes. 2022 Aug 17;15:2521-2534. doi: 10.2147/DMSO.S365192. eCollection 2022. Diabetes Metab Syndr Obes. 2022. PMID: 35999869 Free PMC article. Clinical Trial.
• Effect of Carbohydrate-Restricted Diets and Intermittent Fasting on Obesity, Type 2 Diabetes Mellitus, and Hypertension Management: Consensus Statement of the Korean Society for the Study of Obesity, Korean Diabetes Association, and Korean Society of Hypertension.
  Choi JH, Cho YJ, Kim HJ, Ko SH, Chon S, Kang JH, Kim KK, Kim EM, Kim HJ, Song KH, Nam GE, Kim KI; Committee of Clinical Practice Guidelines, Korean Society for the Study of Obesity (KSSO); Committee of Clinical Practice Guidelines and Committee of Food and Nutrition, Korean Diabetes Association (KDA); Policy Committee of Korean Society of Hypertension (KSH); Policy Development Committee of National Academy of Medicine of Korea (NAMOK). Choi JH, et al. J Obes Metab Syndr. 2022 Jun 30;31(2):100-122. doi: 10.7570/jomes22009. Epub 2022 Jun 7. J Obes Metab Syndr. 2022. PMID: 35670159 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Cambridge University Press
  • Ovid Technologies, Inc.

• Other Literature Sources

  • scite Smart Citations

• Medical

  • MedlinePlus Consumer Health Information
  • MedlinePlus Health Information